Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Person

David Cox

Tracked across 2 events · 12 articles · First seen Apr 29, 2026 · Last active Jun 09, 2026

Sentiment
35
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
6 70
Tech
The University of Oxford and pharmaceutical firm Moderna>>> have developed a pioneering mRNA vaccine, mRNA-4194, aimed at preventing bowel and ovarian cancers in individuals with Hereditary nonpolyposis colorectal cancer>>>. A clinical trial, named Intercept-Lynch, is…
Impact: David Cox>>> is the lead investigator of the Intercept-Lynch trial, providing expert insights and guiding the research into the vaccine's efficacy and potential.
Jun 08, 2026 · 6 articles
4 0
Tech
Impact: David Cox, vice president, AI Foundations at IBM Research, will continue to co-direct the lab.
Apr 29, 2026 · 6 articles
NEWSDESK
Track David Cox live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.